Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

ABS Biotechnologies

ABS Biotechnologies GmbH offers a drug screening platform using blood vessel cells for precision medicine.
2022
1-10
Tulln, Niederosterreich, Austria
  • Bioanalytical Devices
  • Drug Delivery and Devices
  • Drug Discovery and Development
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information